Drug Profile
Naloxone sublingual - INSYS Therapeutics
Alternative Names: Naloxone SL spray - Insys TherapeuticsLatest Information Update: 22 Feb 2022
Price :
$50
*
At a glance
- Originator INSYS Therapeutics, Inc
- Class Antidotes; Behavioural disorder therapies; Benzofurans; Drug withdrawal therapies; Isoquinolines; Ketones; Laxatives; Morphinans; Small molecules
- Mechanism of Action Opioid mu receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Opioid-related disorders
Most Recent Events
- 22 Feb 2022 Discontinued - Phase-III for Opioid-related disorders in USA (Sublingual)
- 24 Oct 2016 Chemical structure information added
- 17 Oct 2016 Phase-III clinical trials in Opioid abuse in USA (Sublingual) (INSYS Therapeutics pipeline, October 2016)